ClinicalTrials.Veeva

Menu

Water Exchange (WE) vs. WE Plus Cap-assisted Colonoscopy (VA)

V

VA Greater Los Angeles Healthcare System

Status

Active, not recruiting

Conditions

Real-time Maximum Insertion Pain
Colonoscopy

Treatments

Device: cap
Other: Water

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

Details and patient eligibility

About

Water exchange (WE) method has been shown to reduce medication requirement and pain experience during the colonoscopy. Cap-assisted colonoscopy aided by air may also reduced the insertion pain. Therefore, the immediate aim of this study is to assess the generalizability of the impact of WE plus cap (WECAC), as a potentially less painful insertion technique than WE. The control group will use water infusion in lieu of air insufflation during insertion of the colonoscope. The study group will added a cap onto the end of colonoscope during the WE method procedure. This study will also demonstrate if the WECAC method have a shorter insertion time and higher proximal colon adenoma detection rate (ADR) than WE alone in Veterans.

Enrollment

256 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Informed/educated male and female Veterans undergoing screening, diagnostic or surveillance colonoscopy at participating sites, choosing scheduled unsedated colonoscopy for any reason

Exclusion criteria

  • Decline to be randomized
  • Unable to give consent or respond to questionnaires
  • History of colon surgery, active inflammatory bowel disease, lower gastrointestinal bleeding
  • Therapeutic colonoscopy, proctosigmoidoscopy, bidirectional endoscopy
  • Inadequate consumption of bowel preparation
  • Known history of severe diverticulosis or diverticulitis
  • History of abdominal surgery previously requiring sedation for colonoscopy
  • Current narcotic/anxiolytic medication use
  • Prior unsuccessful experience with unsedation colonoscopy
  • Emergent colonoscopy
  • Evidence of colonic obstruction based on pre-colonoscopy clinical evaluation
  • Current participation in other studies
  • Medical condition that could increase the risk associated with colonoscopy
  • Medical condition that would preclude a benefit from colonoscopic screening
  • Prosthetic heart valve
  • Anticoagulant therapy
  • Nonmedical problems
  • Need for special precautions in performing colonoscopy
  • Request of on demand sedation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

256 participants in 2 patient groups

Water exchange (WE)
Active Comparator group
Description:
This group will have the air in the colon removed and replaced with water to guide the insertion of the colonoscope.
Treatment:
Other: Water
WE plus cap(WECAC)
Experimental group
Description:
The procedure of this group is similar with WE group, except a cap will be fitted onto the end of the colonoscope.
Treatment:
Device: cap
Other: Water

Trial contacts and locations

2

Loading...

Central trial contact

Nora Jamgotchian, MS; Felix W Leung, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems